Chronic constipation: A critical review
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Chronic constipation is a very common symptom that is rarely associated with life-threatening diseases, but has a substantial impact on patient quality of life and consumption of healthcare resources. Despite the large number of affected patients and the social relevance of the condition, no cost-effectiveness analysis has been made of any diagnostic or therapeutic algorithm, and there are few data comparing different diagnostic and therapeutic approaches in the long term. In this scenario, increasing emphasis has been placed on demonstrating that a number of older and new therapeutic options are effective in treating chronic constipation in well-performed randomised controlled trials, but there is still debate as to when these therapeutic options should be included in diagnostic and therapeutic algorithms. The aim of this review is to perform a critical evaluation of the current diagnostic and therapeutic options available for adult patients with chronic constipation in order to identify a rational patient approach; furthermore we attempt to clarify some of the more controversial points to aid clinicians in managing this symptom in a more efficacious and cost-effective manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Simplified assessment of segmental colonic transit
Metcalf, A. M., Phillips, S. F., Zinsmeister, A. R., MacCarty, R. L., Beart, R. W., & Wolff, B. G. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90837-7 · Cited by 928 · cited 3×
“The upper 95th percentile in healthy subjects is 68 h [73].”
BackgroundChronic constipation: a survey of the patient perspective
JOHANSON, J. F., & KRALSTEIN, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03238.x · Cited by 617
A placebo-controlled trial of prucalopride for severe chronic constipation
Camilleri, M., Kerstens, R., Rykx, A., & Vandeplassche, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800670 · Cited by 576 · cited 1×
“A third definition used in clinical trials is a modified version of the Rome criteria in which abnormal bowel frequency (<3 bowel movements/week) is the necessary condition for inclusion [15–19].”
MethodTwo randomized trials of linaclotide for chronic constipation
Lembo, A. J., Schneier, H. A., Shiff, S. J., Kurtz, C. B., MacDougall, J. E., Jia, X. D., Shao, J. Z., Lavins, B. J., Currie, M. G., Fitch, D. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010863 · Cited by 373 · cited 1×
“A third definition used in clinical trials is a modified version of the Rome criteria in which abnormal bowel frequency (<3 bowel movements/week) is the necessary condition for inclusion [15–19].”
MethodTack, J., Camilleri, M., Chang, L., Chey, W. D., Galligan, J. J., Lacy, B. E., Müller‐Lissner, S., Quigley, E. M. M., Schuurkes, J., De Maeyer, J. H., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05011.x · Cited by 286
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation
Kamm, M. A., Mueller–Lissner, S., Wald, A., Richter, E., Swallow, R., & Gessner, U. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.026 · Cited by 257
Wong, R. K., Palsson, O. S., Turner, M. J., Levy, R. L., Feld, A. D., von Korff, M., & Whitehead, W. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.200 · Cited by 204 · cited 2×
“These observations suggest a continuum based on the everity of pain or discomfort [23], but do not exclude the possiility that the patients at the two extremes of the spectrum may enefit more from treatment aimed specifically at relieving abdomnal pain or correcting the defecation disorder/colonic transit.”
BackgroundCorazziari, E., Badiali, D., Bazzocchi, G., Bassotti, G., Roselli, P., Mastropaolo, G., Lucà, M. G., Galeazzi, R., & Peruzzi, E. (2000) · Gut · doi:10.1136/gut.46.4.522 · Cited by 202 · cited 1×
“How long the patients should be treated and the long-term safety profile of treatments remain relatively unknown, although PEG and prucalopride have been safely used for more than two years [93,94].”
Background
Cited by
Chronic constipation: A review of literature
Forootan, M., Bagheri, N., & Darvishi, M. (2018) · Medicine · doi:10.1097/md.0000000000010631 · Cited by 364
Dimidi, E., Christodoulides, S., Fragkos, K. C., Scott, S. M., & Whelan, K. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.089151 · Cited by 316
“Bulking agents, osmotic laxatives, stimulant laxatives, and stool softeners are commonly used (8, 9).”
BackgroundSerra, J., Pohl, D., Azpiroz, F., Chiarioni, G., Ducrotté, P., Gourcerol, G., Hungin, A. P. S., Layer, P., Mendive, J., Pfeifer, J., et al. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13762 · Cited by 244
Sharma, A., Rao, S. S. C., Kearns, K., Orleck, K. D., & Waldman, S. A. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16369 · Cited by 84
Martoni, C. J., Evans, M., Chow, C. T., Chan, L. S., & Leyer, G. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12797 · Cited by 67
Metadata
- Authors
- Basilisco, G., & Coletta, M.
- Venue
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 45
- Issue
- 11
- Pages
- 886-893
- ISSN
- 1590-8658 (ISSN-L)
- OpenAlex
- W2002179329
- Cited by
- 119
- References
- 9
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic constipation: A critical review. https://app.cochat.ai/papers/10.1016/j.dld.2013.03.016
- The paper
- Basilisco, G., & Coletta, M. (2013). Chronic constipation: A critical review. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2013.03.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.